市場調查報告書
商品編碼
1235067
美國透析市場規模,按類型,按產品/服務,按最終用途,行業分析報告,增長潛力,適用性,競爭市場份額和預測,2023-2032U.S. Dialysis Market Size, By Type, By Product & Service, By End-use, Industry Analysis Report, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032 |
由於與生活方式改變相關的糖尿病激增,美國的透析市場預計將在 2032 年之前顯著增長。
慢性病的增加、美國透析領域的科學技術進步、人口老齡化以及家庭透析需求的增加是推動該行業發展的一些主要因素。 此外,可支配收入的增加和醫療保健成本的增加預計將改善美國透析行業的前景。
新興市場參與者正在投資研發計劃,以開發突破性技術來提高患者護理質量。 例如,2021 年 3 月,百特 (Baxter) 的 AK98(人工腎 98)透析機獲得美國 FDA 批准。 該設備旨在用於離散超濾治療以及急性或慢性液體超負荷和腎功能衰竭患者的間歇性血液透析。 預計這將進一步增加公司在市場上的影響力。
美國透析市場按類型、應用、最終用途和區域劃分。
按類型劃分,由於在醫療程序中越來越多地使用創新和技術先進的設備,腹膜透析預計將在預計的時間表內擴大。 此外,腹膜透析與血液透析相比有幾個優點,例如飲食限制減少、生活方式選擇自由以及需要經常去醫院就診。
由於對透析治療作為腎臟疾病治療的一部分的需求不斷增長,到 2022 年,消耗品領域的銷售額將超過 58 億美元。 市場擴張是由確保有效治療的導管等消耗品的開發推動的。 隨著透析治療的普及,對透析必需耗材的需求將增加,這有望刺激市場增長。
在最終用途方面,由於生活質量提高、差旅成本降低、靈活性和患者移動方便等好處,預計家庭透析在未來幾年內將顯著增長。
按區域劃分,太平洋中央透析市場預計從 2023 年到 2032 年的複合年增長率將超過 3.5%。 這是由於該地區疾病負擔高、私有化程度不斷提高、醫療保險普及率不斷提高、合格衛生人員數量不斷增加以及人口老齡化、易患多種慢性病等背景下取得的快速進展。
The U.S. Dialysis Market is expected to grow considerably through 2032 owing to the surging prevalence of diabetes in the U.S. given a drastic change in lifestyle.
Growing incidences of chronic diseases, scientific and technical breakthroughs in dialysis in the United States, an aging population, as well as rising demand for at-home dialysis are some of the key factors expected to drive industry growth. Additionally, rising disposable income and higher healthcare costs are anticipated to improve the U.S. dialysis industry outlook.
Leading market players are investing in R&D initiatives to develop breakthrough technologies to improve the quality of patient care. For instance, in March 2021, Baxter received U.S. FDA approval in March 2021 for its AK98 (Artificial kidney 98) dialysis machine. The device is meant to be employed for intermittent hemodialysis as well as isolated ultrafiltration therapies for individuals with acute or chronic fluid overload or renal failure. The move is likely to bolster the company's prominence in the market.
The U.S. dialysis market has been divided in terms of type, application, end-use, and zone.
Based on type, peritoneal dialysis is anticipated to expand through the forecast timeline due to the increasing use of innovative and technically advanced devices during medical procedures. Moreover, peritoneal dialysis boasts of several benefits over hemodialysis, including fewer dietary restrictions, more freedom over lifestyle choices, and no need for frequent hospital visits.
With respect to application, the consumables segment held more than USD 5.8 billion in revenue in 2022 credited to the rising requirement for dialysis therapy as a form of kidney disease treatment. The market expansion is expedited by developments in consumables including catheters, which guarantee effective therapy. The use of dialysis therapy will increase demand for the supplies needed for the operation, fueling segmental growth.
In terms of end-use, the home dialysis segment is poised to grow significantly over the review years attributed to the several advantages it offers, including better quality of life, lower travel costs, flexibility, and simple patient mobility, leading to a rise in its adoption.
Based on zone, the Pacific Central dialysis market is speculated to grow at more than 3.5% CAGR from 2023 to 2032 driven by the massive disease burden in the region, rising privatization, rising health insurance penetration, aggravating efforts to increase the number of qualified health care personnel, and the rapidly aging population susceptible to several chronic illnesses.